Marijuana Stocks Money

Positioning in the pot stock market is one of the most important aspects to consider. Given that pot stocks as an industry, has so many facets, finding a niche becomes ever more important. Within the market, there are several sub-sectors including money transport, extraction companies, branding and packaging, and many more. Because of the broad scope of the industry, investors are not at all limited to just a few pot stocks. With great power, however, comes great responsibility.

This responsibility comes in the form of due diligence and proper research. One of the key factors that separate the pro investors from those at the amateur level is the amount of research that they are able to put in. Information is so widely available given the power of the internet, that it should be easier than ever to find out the financials of a given company. There are many factors to a pot stock investment, and they all need to be researched equally. With the future of pot stocks looking brighter than ever, here are two pot stocks that look to be right in the prime market position.

A Health and Wellness Pot Stock

1933 Industries Inc. (TGIFF Stock Report) (TGIF) is one of the leading vertically integrated cannabis brands working in the U.S. and Canada. The company operates through two wholly-owned subsidiaries. With these assets, they are able to be of the leading cannabis brands across the industry. They participate in cannabis cultivation, extraction, processing and the manufacturing of assets. With its wide portfolio of assets, the company has been working to move deeper into the health and wellness market.

The company recently announced that their newest product known as Birdhouse CBD Balm by Canna Hemp X, will be available in many dispensaries, wellness stores, skate shops, and other specialty retail stores. The scope of this new product is one of the main reasons that so many investors believe that this is a key pot stock to watch. Focusing on the health and wellness market has become one of the best decisions that the company has made. This sector of the industry is one of the fastest-growing aspects of the market which is just the reason that they have chosen to participate so heavily within it. For this reason, they remain a key marijuana stock to watch.

Another Alternative Pot Stock Worth Watching

KushCo Holdings (KSHB Stock Report) is considered to be one of the leaders in the ancillary pot stock market. The company has seen as much as $230 million forecasted for the next year of their business. The company has traditionally been in the marketing and advertising aspect of the pot stock market. This later evolved into them diving into the product market by producing extracts in the form of cannabis oils and other products.

With their newest venture looking to be the hemp plant, the company has secured a bright future for themselves moving forward. The company has also stated that their new hemp venture should help them to produce around $25 million in sales by the year 2020. For this reason, they continue to be an interesting pot stock to watch.

how to buy marijuana stocks

Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and 1933 Industries Inc. (TGIFF) (TGIF), Midam is being paid $25,000 a month for coverage on 1933 Industries Inc. (TGIFF) (TGIF), for a period from August 1, 2019 to February 1, 2020. As of September 1, 2019, we have been paid $75,000.  We may buy or sell additional shares of 1933 Industries Inc. (TGIFF) (TGIF) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about 1933 Industries Inc. (TGIFF) (TGIF). For Full Disclaimer Click Here 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Which U.S. Senator Changed their View on #Marijuana?

Elizabeth Warren – U.S. senator and democratic darling – said that she…

$OXIS Biotech, Inc. Licenses Worldwide Rights to Cancer Therapy with Positive FDA Phase I Study Results

Oxis Biotech, a wholly-owned subsidiary of Oxis International, Inc. (OTCQB: OXIS) is…